Robert Y. Moore

University of Pittsburgh University of Pittsburgh, Pittsburgh, PA, United States 
neuroanatomy, Parkinson’s disease; Huntington’s disease; movement disorders; regulation and disorders of sleep and wake
"Robert Moore"
Cross-listing: Neurotree - Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Moore RY. (2016) Calretinin Neurons in the Rat Suprachiasmatic Nucleus. Journal of Biological Rhythms
Moore RY. (2013) The suprachiasmatic nucleus and the circadian timing system. Progress in Molecular Biology and Translational Science. 119: 1-28
Leak RK, Moore RY. (2012) Innervation of ventricular and periventricular brain compartments. Brain Research. 1463: 51-62
Parent B, Awan N, Berman SB, et al. (2011) The relevance of age and disease duration for intervention with subthalamic nucleus deep brain stimulation surgery in Parkinson disease. Journal of Neurosurgery. 114: 927-31
Pavese N, Moore RY, Scherfler C, et al. (2010) In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study. Experimental Neurology. 222: 120-4
Moore RY. (2009) Circadian Timing and Sleep-Wake Regulation Sleep Disorders Medicine. 105-111
Bohnen NI, Gedela S, Herath P, et al. (2008) Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neuroscience Letters. 447: 12-6
Hall AM, Moore RY, Lopez OL, et al. (2008) Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 271-9
Bohnen NI, Studenski SA, Constantine GM, et al. (2008) Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 15: 685-91
Moore RY, Whone AL, Brooks DJ. (2008) Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study. Neurobiology of Disease. 29: 381-90
See more...